share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:擬議出售證券
SEC announcement ·  04/02 16:38
Moomoo AI 已提取核心訊息
Ginkgo Bioworks Holdings, Inc. officer Mark E. Dmytruk is set to sell 51,169 Class A shares on April 2, 2024, with an aggregate market value of $53,667.78. The shares were acquired on April 1, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a three-month period where Dmytruk sold a total of 124,189 shares, generating gross proceeds of $167,121.55.
Ginkgo Bioworks Holdings, Inc. officer Mark E. Dmytruk is set to sell 51,169 Class A shares on April 2, 2024, with an aggregate market value of $53,667.78. The shares were acquired on April 1, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a three-month period where Dmytruk sold a total of 124,189 shares, generating gross proceeds of $167,121.55.
Ginkgo Bioworks Holdings, Inc.高管馬克·德米特魯克定於2024年4月2日出售51,169股A類股票,總市值爲53,667.78美元。這些股票於2024年4月1日作爲限制性股票歸屬的一部分被收購,被視爲發行人的補償。該交易是在三個月內Dmytruk共出售了124,189股股票之後進行的,總收益爲167,121.55美元。
Ginkgo Bioworks Holdings, Inc.高管馬克·德米特魯克定於2024年4月2日出售51,169股A類股票,總市值爲53,667.78美元。這些股票於2024年4月1日作爲限制性股票歸屬的一部分被收購,被視爲發行人的補償。該交易是在三個月內Dmytruk共出售了124,189股股票之後進行的,總收益爲167,121.55美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息